Aspiriant LLC’s TransDigm Group TDG Stock Holding History

Aspiriant LLC’s Portfolio TDG Stock Details TDG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	2,002 +2	+0.1%	+$2.46K	0.07%	94
2026 Q1	$2.32M	Sell	2,000 -1	-0%	-$1.31K	0.07%	99
2025 Q4	$2.66M	Buy	2,001 +1	+0.1%	+$1.31K	0.08%	94
2025 Q3	$2.64M	Sell	2,000 -6	-0.3%	-$8.58K	0.08%	87
2025 Q2	$3.05M	Sell	2,006 -14	-0.7%	-$19.7K	0.1%	86
2025 Q1	$2.79M	Buy	2,020 +7	+0.3%	+$9.33K	0.1%	81
2024 Q4	$2.55M	Buy	2,013 +12	+0.6%	+$15.8K	0.09%	86
2024 Q3	$2.86M	Buy	+2,001	New	+$2.6M	0.11%	79

Other funds holding TDG

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aspiriant LLC's TDG Position: Q2 2026 in Review

Aspiriant LLC increased its TransDigm Group (TDG) stake by 0.1% in Q2 2026, buying an estimated $2.46K and bringing the position to 2,002 shares worth $2.67M. The position accounts for 0.07% of the portfolio, ranked #94.

Aspiriant LLC first reported a position in TDG in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.05M in Q2 2025. 1,143 funds tracked by Wall St. Rank hold TDG as of Q2 2026.

Aspiriant LLC held 2,002 shares of TransDigm Group worth $2.67M as of Q2 2026.
Aspiriant LLC bought 2 TransDigm Group shares in Q2 2026, an estimated $2.46K.
TransDigm Group made up 0.07% of Aspiriant LLC's portfolio in Q2 2026, its #94 holding.
Aspiriant LLC first reported a position in TransDigm Group in Q3 2024 and has held it in 8 quarters since.
Aspiriant LLC's TransDigm Group position peaked at $3.05M in Q2 2025.
1,143 funds tracked by Wall St. Rank held TransDigm Group as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.